ASX:COHMedical Equipment
Cochlear (ASX:COH) Draws Fresh Investor Attention, Is The Recovery Already Priced In?
Cochlear (ASX:COH) is back in focus after a 2.26% share price rise, following a one year decline of 59.17%. Investors are reassessing healthcare stocks amid improving patient activity and operational execution.
See our latest analysis for Cochlear.
The recent 27.29% 1 month share price return contrasts with a 51.01% decline year to date and a 56.63% fall in the 1 year total shareholder return. Cochlear's short term momentum is improving, while longer term performance remains weak as investors...